EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CASCADE-Cas3 enables highly efficient genome engineering in Streptomyces species

Christopher M Whitford iD, Peter Gockel, David Faurdal, Tetiana Gren, Renata Sigrist, Tilmann Weber iD

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Christopher M Whitford und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark. Hauptthemen laut MEDLINE: Streptomyces, CRISPR-Cas Systems, Gene Editing, Genome, Bacterial. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, DTU Biosustain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type I clustered regularly interspaced short palindromic repeat (CRISPR) systems are widespread in bacteria and archaea. Compared to more widely applied type II systems, type I systems differ in the multi-effector CRISPR-associated complex for antiviral defense needed for crRNA processing and target recognition, as well as the processive nature of the hallmark nuclease Cas3. Given the widespread nature of type I systems, the processive nature of Cas3 and the recombinogenic overhangs created by Cas3, we hypothesized that CASCADE-Cas3 would be uniquely positioned to enable efficient genome engineering in streptomycetes. Here, we report a new type I based CRISPR genome engineering tool for streptomycetes. The plasmid system, called pCRISPR-Cas3, utilizes a compact type I-C CRISPR system and enables highly efficient genome engineering. pCRISPR-Cas3 outperforms pCRISPR-Cas9 and facilitates targeted and random sized deletions. Furthermore, we demonstrate its ability to effectively perform substitutions of large genomic regions such as biosynthetic gene clusters. Without additional modifications, pCRISPR-Cas3 enabled genome engineering in several Streptomyces species at high efficiencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptomycesCRISPR-Cas SystemsGene EditingGenome, BacterialGenetic EngineeringCRISPR-Associated ProteinsPlasmids

Substanzen

CRISPR-Associated Proteins

Autor:innen und Institutionen

  • The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.

ORCID-Profile: Christopher M Whitford, Tilmann Weber

Förderung

  • Novo Nordisk Foundation
  • DTU Biosustain

Zitieren

APA

Whitford, C. M., Gockel, P., Faurdal, D., Gren, T., Sigrist, R., & Weber, T. (2025). CASCADE-Cas3 enables highly efficient genome engineering in Streptomyces species. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf214

Vancouver

Whitford CM, Gockel P, Faurdal D, Gren T, Sigrist R, Weber T. CASCADE-Cas3 enables highly efficient genome engineering in Streptomyces species. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf214

BibTeX
@article{Whitford2025,
  author = {Whitford, Christopher M and Gockel, Peter and Faurdal, David and Gren, Tetiana and Sigrist, Renata and Weber, Tilmann},
  title = {CASCADE-Cas3 enables highly efficient genome engineering in Streptomyces species},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf214}
}
Kostenlos starten →